01—Abstract
Summary
Summary of the 8-K filed July 10, 2024. Cited figures are marked; the original filing is the authoritative source.
Edwards Lifesciences Corporation (EW) has announced a significant addition to its Board of Directors with the appointment of David T.
Feinberg, M.D., effective immediately. Dr. Feinberg brings a wealth of experience spanning nearly three decades in health system management and health information technology services. His extensive background includes leadership roles at prominent organizations such as Oracle Health (Chairman), Cerner Corporation (CEO), Google Health (Vice President), and Geisinger Health (President and CEO), as well as significant experience within UCLA Health.
This appointment is particularly noteworthy given Dr. Feinberg's deep expertise in healthcare operations, technology, and quality improvement, which are highly relevant to Edwards Lifesciences' mission in advanced medical technologies. His role as a member of the Board's Audit Committee will further enhance the board's oversight capabilities. Investors may view this as a positive development, signaling a continued focus on strategic growth and operational excellence within the company.
02—Key points
Key Highlights
- Appointment of David T. Feinberg, M.D. to the Board of Directors, effective immediately.
- Dr. Feinberg brings extensive experience in health system management and health information technology.
- He has held leadership positions at Oracle Health, Cerner Corporation, Google Health, and Geisinger Health.
- Dr. Feinberg has also served in significant roles at UCLA Health.
- He has prior public company board experience with Humana, Douglass Emmett, Inc., and OSI Systems.
- Dr. Feinberg has been appointed as a member of the Board's Audit Committee.
- His appointment is not based on any pre-existing arrangements or material interests, aligning with standard director compensation.
03—Questions
Frequently Asked Questions
Who is David T. Feinberg, M.D. and what is his relevance to Edwards Lifesciences?
David T. Feinberg, M.D. is a new member of the Edwards Lifesciences Board of Directors. He has nearly 30 years of experience in health system and health information technology services management. His background includes CEO roles at Cerner and Geisinger Health, a Vice President position at Google Health, and Chairmanship at Oracle Health. This extensive experience in healthcare leadership and technology is highly relevant to Edwards Lifesciences' business.
What role will Dr. Feinberg play on the Board?
Dr. Feinberg has been appointed to the Edwards Lifesciences Board of Directors and will serve as a member of the Audit Committee. This suggests he will contribute to the oversight of financial reporting, internal controls, and risk management.
Are there any special compensation or unusual arrangements associated with Dr. Feinberg's appointment?
No, the filing states there are no special arrangements or understandings for his selection. Dr. Feinberg will receive standard pro rata compensation for non-employee directors as outlined in the company's proxy statement and will enter into the company's standard indemnification agreement.
Does Dr. Feinberg have any conflicts of interest with Edwards Lifesciences?
According to the filing, Dr. Feinberg has no direct or indirect material interest in any transaction that would require disclosure under Regulation S-K, and there are no arrangements or understandings between him and other persons regarding his selection as director.
04—Continue